Characterization of the SAM domain of the PKD-related protein ANKS6 and its interaction with ANKS3

BMC Structural Biology

Volumn 14, Issue 1, 2014, Pages

  Leettola, Catherine N ^a   Knight, Mary Jane ^a   Cascio, Duilio ^a   Hoffman, Sigrid ^b   Bowie, James U ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Crystal structure; Polycystic kidney disease; Polymerization; Protein protein interaction

Indexed keywords

ANKYRIN; HETERODIMER; HOMODIMER; PROTEIN; PROTEIN ANKS 3; PROTEIN ANKS 6; UNCLASSIFIED DRUG; ANKS3 PROTEIN, HUMAN; CARRIER PROTEIN; NUCLEAR PROTEIN; SAMCYSTIN PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; CRYSTALLIZATION; GENE MUTATION; HYDROGEN BOND; KIDNEY POLYCYSTIC DISEASE; MOLECULAR WEIGHT; NONHUMAN; POLYMERIZATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RAT; SOLUBILIZATION; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; TRIPLE HELIX; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; HUMAN; METABOLISM; MUTATION; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANKYRIN REPEAT; BINDING SITES; CARRIER PROTEINS; CIRCULAR DICHROISM; HUMANS; MODELS, MOLECULAR; MUTATION; NUCLEAR PROTEINS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RATS; SURFACE PLASMON RESONANCE;

EID: 84903666144     PISSN: None     EISSN: 14726807     Source Type: Journal    
DOI: 10.1186/1472-6807-14-17     Document Type: Article

References (60)

1. Polycystic kidney disease. Wilson PD, N Engl J Med 2004 350 151 164 (Pubitemid 38056226)
2. The cell biology of polycystic kidney disease. Chapin HC, Caplan MJ, J Cell Biol 2010 191 701 710
3. Autosomal dominant polycystic kidney disease. Torres VE, Harris PC, Pirson Y, The Lancet 2007 369 1287 1301 (Pubitemid 46552051)
4. Autosomal dominant polycystic kidney disease. Gabow PA, N Engl J Med 1993 329 332 342 (Pubitemid 23210687)
5. A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes. Ariza M, Alvarez V, Marin R, Aguado S, López-Larrea C, Alvarez J, Menéndez MJ, Coto E, J Med Genet 1997 34 587 589 (Pubitemid 27315641)
6. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, Sukhatme VP, Guggino WB, Germino GG, Nature 2000 408 990 994 (Pubitemid 32101647)
7. Animal models for human polycystic kidney disease. Nagao S, Kugita M, Yoshihara D, Yamaguchi T, Exp Anim 2012 61 477 488
8. Murine models of polycystic kidney diease: molecular and therapeutic insights. Guay-Woodford LM, Am J Physiol-Ren Physiol 2003 285 1034 F1049
9. Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease. Schäfer K, Gretz N, Bader M, Oberbäumer I, Eckardt K-U, Kriz W, Bachmann S, Kidney Int 1994 46 134 152 (Pubitemid 24210445)
10. Rat models of autosomal dominant polycystic kidney disease. Gretz N, Kränzlin B, Pey R, Schieren G, Bach J, Obermüller N, Ceccherini I, Klöting I, Rohemeiss P, Bachmann S, Hafner M, Nephrol Dial Transplant 1996 11 46 51 (Pubitemid 27055657)
11. Missense mutation in sterile motif of novel protein samcystin is associated with polycystic kidney disease in (cy/+) rat. Brown JH, Bihoreau M-T, Hoffmann S, Kränzlin B, Tychinskaya I, Obermüller N, Podlich D, Boehn SN, Kaisaki PJ, Megel N, Danoy P, Copley RR, Broxholme J, Witzgall R, Lathrop M, Gretz N, Gauguier D, J Am Soc Nephrol 2005 16 3517 3526 (Pubitemid 46211272)
12. Transgenic overexpression of Anks6(p.R823W) causes polycystic kidney disease in rats. Neudecker S, Walz R, Menon K, Maier E, Bihoreau M-T, Obermüller N, Kränzlin B, Gretz N, Hoffmann SC, Am J Pathol 2010 177 3000 3009
13. ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Hoff S, Halbritter J, Epting D, Frank V, Nguyen T-MT, van Reeuwijk J, Boehlke C, Schell C, Yasunaga T, Helmstädter M, Mergen M, Filhol E, Boldt K, Horn N, Ueffing M, Otto EA, Eisenberger T, Elting MW, van Wijk JAE, Bockenhauer D, Sebire NJ, Rittig S, Vyberg M, Ring T, Pohl M, Pape L, Neuhaus TJ, Elshakhs NAS, Koon SJ, Harris PC, et al. Nat Genet 2013 45 951 956
14. The many faces of SAM. Qiao F, Bowie JU, Sci STKE 2005 2005 e7
15. SAM domains: uniform structure, diversity of function. Kim CA, Bowie JU, Trends Biochem Sci 2003 28 625 628 (Pubitemid 37500895)
16. Regulation of enzyme localization by polymerization: polymer formation by the SAM domain of diacylglycerol kinase δ1. Harada BT, Knight MJ, Imai S, Qiao F, Ramachander R, Sawaya MR, Gingery M, Sakane F, Bowie JU, Structure 2008 16 380 387 (Pubitemid 351324112)
17. The SAM domain of polyhomeotic forms a helical polymer. Kim CA, Gingery M, Pilpa RM, Bowie JU, Nat Struct Biol 2002 9 453 457 (Pubitemid 34568791)
18. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. Kim CA, Phillips ML, Kim W, Gingery M, Tran HH, Robinson MA, Faham S, Bowie JU, EMBO J 2001 20 4173 4182 (Pubitemid 32751833)
19. An architectural framework that may lie at the core of the postsynaptic density. Baron MK, Boeckers TM, Vaida B, Faham S, Gingery M, Sawaya MR, Salyer D, Gundelfinger ED, Bowie JU, Science 2006 311 531 535 (Pubitemid 43157732)
20. Tandem SAM domain structure of human Caskin1: a presynaptic, self-assembling scaffold for CASK. Stafford RL, Hinde E, Knight MJ, Pennella MA, Ear J, Digman MA, Gratton E, Bowie JU, Structure 2011 19 1826 1836
21. Regulation of clathrin adaptor function in endocytosis: novel role for the SAM domain. Di Pietro SM, Cascio D, Feliciano D, Bowie JU, Payne GS, EMBO J 2010 29 1033 1044
22. A human sterile alpha motif domain polymerizome. Knight MJ, Leettola C, Gingery M, Li H, Bowie JU, Protein Sci 2011 20 1697 1706
23. Oligomerization-dependent Association of the SAM Domains from Schizosaccharomyces pombe Byr2 and Ste4. Ramachander R, Kim CA, Phillips ML, Mackereth CD, Thanos CD, McIntosh LP, Bowie JU, J Biol Chem 2002 277 39585 39593 (Pubitemid 35190938)
24. Derepression by depolymerization: structural insights into the regulation of Yan by Mae. Qiao F, Song H, Kim CA, Sawaya MR, Hunter JB, Gingery M, Rebay I, Courey AJ, Bowie JU, Cell 2004 118 163 173 (Pubitemid 38962573)
25. The solution structure of the S.cerevisiae Ste11 MAPKKK SAM Domain and its partnership with Ste50. Kwan JJ, Warner N, Pawson T, Donaldson LW, J Mol Biol 2004 342 681 693 (Pubitemid 39149766)
26. Structure of the sterile Motif (SAM) domain of the saccharomyces cerevisiae mitogen-activated protein kinase pathway-modulating protein STE50 and analysis of its interaction with the STE11 SAM. Grimshaw SJ, Mott HR, Stott KM, Nielsen PR, Evetts KA, Hopkins LJ, Nietlispach D, Owen D, J Biol Chem 2003 279 2192 2201 (Pubitemid 38084493)
27. The Sam domain of the lipid phosphatase Ship2 adopts a common model to interact with Arap3-Sam and EphA2-Sam. Leone M, Cellitti J, Pellecchia M, BMC Struct Biol 2009 9 59
28. Mae inhibits Pointed-P2 transcriptional activity by blocking its MAPK docking site. Qiao F, Harada B, Song H, Whitelegge J, Courey AJ, Bowie JU, EMBO J 2005 25 70 79 (Pubitemid 43077296)
29. BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Zhang H, Xu Q, Krajewski S, Krajewska M, Xie Z, Fuess S, Kitada S, Pawlowski K, Godzik A, Reed JC, PNAS 2000 97 2597 2602 (Pubitemid 30159216)
30. The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators. Aviv T, Lin Z, Rendl LM, Sicheri F, Smibert CA, Nat Struct Biol 2003 10 614 621 (Pubitemid 36944714)
31. Binding of the C-terminal sterile Motif (SAM) domain of human p73 to lipid membranes. Barrera FN, Poveda JA, González-Ros JM, Neira JL, J Biol Chem 2003 278 46878 46885 (Pubitemid 37452269)
32. Structural organization of a sex-comb-on-midleg/Polyhomeotic copolymer. Kim CA, Sawaya MR, Cascio D, Kim W, Bowie JU, J Biol Chem 2005 280 27769 27775 (Pubitemid 41076891)
33. CNK and HYP form a discrete dimer by their SAM domains to mediate RAF kinase signaling. Rajakulendran T, Sahmi M, Kurinov I, Tyers M, Therrien M, Sicheri F, Proc Natl Acad Sci 2008 105 2836 2841 (Pubitemid 351723630)
34. NMR studies of a heterotypic Sam-Sam domain association: the interaction between the lipid phosphatase Ship2 and the EphA2 Receptor. Leone M, Cellitti J, Pellecchia M, Biochemistry 2008 47 12721 12728
35. Zinc binding drives sheet formation by the SAM domain of diacylglycerol kinase δ Knight MJ, Joubert MK, Plotkowski ML, Kropat J, Gingery M, Sakane F, Merchant SS, Bowie JU, Biochemistry 2010 49 9667 9676
36. A role for zinc in postsynaptic density asSAMbly and plasticity? Gundelfinger ED, Boeckers TM, Baron MK, Bowie JU, Trends Biochem Sci 2006 31 366 373 (Pubitemid 44056319)
37. Supercharging proteins can impart unusual resilience. Lawrence MS, Phillips KJ, Liu DR, J Am Chem Soc 2007 129 10110 10112 (Pubitemid 47312950)
38. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase. Grucza RA, Bradshaw JM, Mitaxov V, Waksman G, Biochemistry 2000 39 10072 10081 (Pubitemid 30663028)
39. Thermodynamic analysis of the heparin interaction with a basic cyclic peptide using isothermal titration calorimetry. Hileman RE, Jennings RN, Linhardt RJ, Biochemistry 1998 37 15231 15237 (Pubitemid 28503252)
40. Polymer-driven crystallization. Nauli S, Farr S, Lee Y-J, Kim H-Y, Faham S, Bowie JU, Protein Sci 2007 16 2542 2551 (Pubitemid 350036759)
41. Positional cloning of jcpk/bpk locus of the mouse. Cogswell C, Price SJ, Hou X, Guay-Woodford LM, Flaherty L, Bryda EC, Mamm Genome 2003 14 242 249 (Pubitemid 36408151)
42. The polycystic kidney disease-related proteins Bicc1 and SamCystin interact. Stagner EE, Bouvrette DJ, Cheng J, Bryda EC, Biochem Biophys Res Commun 2009 383 16 21
43. Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling. Kugita M, Nishii K, Morita M, Yoshihara D, Kowa-Sugiyama H, Yamada K, Yamaguchi T, Wallace DP, Calvet JP, Kurahashi H, Nagao S, AJP Ren Physiol 2010 300 177 F188
44. Structure of the dimerization domain of DiGeorge Critical Region 8. Senturia R, Faller M, Yin S, Loo JA, Cascio D, Sawaya MR, Hwang D, Clubb RT, Guo F, Protein Sci 2010 19 1354 1365
45. Screening of peptide libraries linked to lac repressor. Schatz PJ, Cull MG, Martin EL, Gates CM, Methods Enzymol 1996 267 171 191 (Pubitemid 26159222)
46. SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD, Butt TR, J Struct Funct Genomics 2004 5 75 86 (Pubitemid 39030623)
47. XDS. Kabsch W, Acta Crystallogr D Biol Crystallogr 2010 66 125 132
48. HKL2MAP: a graphical user interface for macromolecular phasing with SHELX programs. Pape T, Schneider TR, J Appl Crystallogr 2004 37 843 844
49. Experimental phasing with SHELXC/D/E: combining chain tracing with density modification. Sheldrick GM, Acta Crystallogr D Biol Crystallogr 2010 66 479 485
50. Overview of the CCP 4 suite and current developments. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AGW, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, Read RJ, Vagin A, Wilson KS, Acta Crystallogr D Biol Crystallogr 2011 67 235 242
51. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung L-W, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH, Acta Crystallogr D Biol Crystallogr 2010 66 213 221
52. Features and development of Coot. Emsley P, Lohkamp B, Scott WG, Cowtan K, Acta Crystallogr D Biol Crystallogr 2010 66 486 501
53. Linking crystallographic model and data quality. Karplus PA, Diederichs, Science 2012 336 1030 1033
54. Phaser crystallographic software. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ, J Appl Crystallogr 2007 40 658 674 (Pubitemid 47080256)
55. PROCHECK: a program to check the stereochemical quality of protein structures. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, J Appl Crystallogr 1993 26 283 291
56. Verification of protein structures: patterns of nonbonded atomic interactions. Colovos C, Yeates TO, Protein Sci 1993 2 1511 1519 (Pubitemid 23262844)
57. A method to identify protein sequences that fold into a known three-dimensional structure. Bowie JU, Lüthy R, Eisenberg D, Science 1991 253 164 170 (Pubitemid 21917131)
58. The PyMOL Molecular Graphics System, Version 1.3. Schrödinger LLC, 2010
59. Electrostatics of nanosystems: application to microtubules and the ribosome. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA, Proc Natl Acad Sci 2001 98 10037 10041 (Pubitemid 32802969)
60. Inference of macromolecular assemblies from crystalline state. Krissinel E, Henrick K, J Mol Biol 2007 372 774 797 (Pubitemid 47321791)